| Cases | ANXA4 (+)(%) | p value | FLNA (+)(%) | p value |
---|---|---|---|---|---|
Gender | Â | Â | Â | Â | Â |
  Male | 83 | 59(71.1) | 0.455 | 57(68.7) | 0.425 |
  Female | 11 | 9(81.8) |  | 5(45.5) |  |
Age | Â | Â | Â | Â | Â |
  ≤40 yr | 42 | 32(76.2) | 0.453 | 28(66.7) | 0.896 |
  >40 yr | 52 | 36(69.2) |  | 34(65.4) |  |
T stage | Â | Â | Â | Â | Â |
  T1 | 8 | 3(37.5) | 0.017* | 2(25) | 0.042* |
  T2 | 44 | 29(65.9) |  | 28(63.6) |  |
  T3 | 36 | 30(83.3) |  | 27(75) |  |
  T4 | 6 | 6(100) |  | 5(83.3) |  |
N Stage | Â | Â | Â | Â | Â |
  N0 | 48 | 27(56.3) | 0.001* | 38(79.2) | 0.017* |
  N1 | 43 | 38(88.4) |  | 23(53.5) |  |
  N2 | 3 | 3(100) |  | 1(33.3) |  |
UICC Stage | Â | Â | Â | Â | Â |
  I | 7 | 2(28.6) | 0.004* | 4(57.1) | 0.696 |
  II | 31 | 19(61.3) |  | 19(61.3) |  |
  III | 50 | 41(82) |  | 34(68) |  |
  IV | 6 | 6(100) |  | 5(83.3) |  |
Diff. | Â | Â | Â | Â | Â |
  Well | 80 | 59(73.8) | 0.652 | 55(68.8) | 0.180 |
  Moderate | 10 | 6(60) |  | 6(60) |  |
  Poor | 4 | 3(75) |  | 1(25) |  |
OSF Stage | Â | Â | Â | Â | Â |
  Early | 27 | 22(81.5) | 0.294 | 16(59.3) | 0.278 |
  Moderated | 46 | 30(65.2) |  | 34(73.9) |  |
  Advanced | 21 | 16(76.2) |  | 12(57.1) |  |